 |
 |
Note: The 2011 Annual Probiotic Symposium was held September 23 & 24, 2011.
A faculty of experts in their fields covered a range of topics demonstrating practical approaches to integrating probiotics into clinical practice making this one of the most informative and useful conferences healthcare practitioners could attend. The conference format was for all healthcare practitioners with every level of expertise whether new to or well-versed in the use of probiotics in the delivery of patient care.
|
| Friday, September 23, 2011 |
7:00 am - 8:15 am
Registration and Breakfast |
 |
8:15 am - 8:30 am
Welcome and Introductory Remarks |
|
8:30 am - 9:30 am
Teach Your Children Well: Gut Microbiota and the Education of the Immune System
Patrick Hanaway, MD |
|
9:30 am - 10:30 am
Laboratory Evaluation of GI Dysbiosis
Paul Schreckenberger, PhD |
|
10:30 am - 11:00 am
Break |
|
11:00 am - noon
Probiotics for Infectious Diseases and Antibiotic-Associated Diarrhea
Andi L. Shane, MD, MPH, MSc |
|
Noon - 1:30 pm
Luncheon |
|
1:30 pm - 2:30 pm
Treatment of GI Disturbances in Autism Spectrum Disorders
Elizabeth Mumper, MD, FAAP |
|
2:30 pm - 3:00 pm
Break |
|
3:00 pm - 4:30 pm
Panel Discussion |
|
4:30 pm - 5:30 pm
Vendor-sponsored presentations |
|
|
| Saturday, September 24, 2011 |
7:30 am - 8:30 am
Breakfast |
|
8:30 am - 9:30 am
Gingivitis, Oral and Systemic Health,
and Probiotics
Mark Cannon, DDS |
|
9:30 am - 10:30 am
Irritable Bowel Syndrome, the Role
of Gut Microflora
Yehuda Ringel, MD |
|
10:30 am - 11:00 am
Break |
|
11:00 am - noon
The Use of Saccharomyces boulardii
as a Probiotic
Yvan Vandenplas, MD, PhD |
|
Noon - 1:30 pm
Luncheon |
|
1:30 pm - 2:30 pm
Practical Applications of Prebiotics and Probiotics
Stephen F. Olmstead, MD |
|
2:30 pm - 3:00 pm
Break |
|
3:00 pm - 4:30 pm
Panel Discussion |
|
|
|
|
|
 |
|
This CME activity has been approved for 11 Category 1 Credits.
This program has been approved by the Commission on Dietetic Registration for 11 CPEUs. |
|
| |
|
|
 |
|
Understand the importance of the intestinal microflora for the normal development and function of the gastrointestinal and immune systems.
Describe mechanisms through which probiotics confer health benefits.
Describe the benefits of culture-based testing for microbial pathogens.
List natural agents and their relative inhibitory activity to bacteria and yeast recovered from the human intestinal tract.
Compare the sensitivity and specificity of culture, enzyme immunoassay, and PCR testing for the detection of Clostridium difficile in stool specimens.
Understand the mechanisms for antibiotic-associated diarrhea.
List ways in which probiotics protect against gastrointestinal pathogens and antibiotic-associated diarrhea.
Describe the evidence for gastrointestinal disorders in children with autism spectrum disorders.
Understand the evidence for the potential role of diet, probiotics, and enzymes in the management of gut inflammation in autism spectrum disorders.
Review the evidence on how gingivitis and periodontal disease are associated with systemic diseases such as atherosclerosis.
Understand how oral probiotics can potentially benefit dental and gingival health and possibly decrease systemic inflammation.
Review the evidence for the nature and prevalence of intestinal microbiota disruption in irritable bowel syndrome and its role in pathogenesis of irritable bowel syndrome.
Understand the basic and clinical research on the unique biotherapeutic properties of Saccharomyces boulardii.
Describe the evidence for clinical conditions that may be prevented and managed using S. boulardii.
Understand the evidence for basic and clinical research on gastrointestinal and extraintestinal disorders that may be prevented or treated using probiotics.
Learn about probiotic regimens for specified conditions that may be beneficial based on relevant clinical studies. |
|
| |
|
|
|
